monosodium urate monohydrate

monosodium urate monohydrate

the monosodium salt of uric acid, deposited as needle-shaped crystals in the joints and other sites in gout.
References in periodicals archive ?
The presence of monosodium urate monohydrate crystals in a symptomatic joint, bursa, or tophus is sufficient to diagnose gout, according to new gout classification criteria from the American College of Rheumatology and the European League Against Rheumatism.
Growth of monosodium urate monohydrate crystals: effect of cartilage and synovial fluid components on in-vitro growth rates.
Gout is a uric acid metabolic disorder which is seen throughout the world and is characterized by recurrent episodes of inflammatory arthritis (2) along with the accumulation of monosodium urate monohydrate (MSU) crystals in soft tissues and diarthrosis.
The etiology of gout is manifested directly in the deposition of monosodium urate monohydrate crystals or uric acid, due to hyperurecimia defined as >6 mg/dL in women and 7 mg/dL in men.
Clinical aspects of monosodium urate monohydrate crystal deposition disease gout.
Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation.
The presence of monosodium urate monohydrate crystals in synovial fluid remains the gold standard for gout diagnosis, with a sensitivity of 84% and a specificity of 100%, according to new gout diagnostic guidelines issued by the European League Against Rheumatism.